- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09.09. | FDA clears Bayer's Hyrnuo in first-line lung cancer, amping up Hernexeos rivalry | ||
| 09.09. | Actor Kevin Costner does the math in Caris Detect early cancer detection push | ||
| 09.09. | Merck trims another 54 jobs in New Jersey amid multiyear cost-cutting initiative | ||
| 09.09. | BioMarin pads case for Voxzogo expansion as achondroplasia competition field shifts | ||
| 09.09. | FDA solidifies CDER, CBER leadership posts as commissioner confirmation awaits | ||
| 08.09. | Sandoz sets sights on 100 biosimilars in new 2040 strategy, with $300M facility build | ||
| 08.09. | Eight Trends Reshaping Patient-Centric Drug Development | ||
| 08.09. | Amgen's DLL3-targeted Imdelltra scores overall survival win in first-line small cell lung cancer | ||
| 08.09. | Novo Nordisk's Wegovy helps free 40% of kids from obesity in phase 3 trial | ||
| 08.09. | FDA approves AstraZeneca's Etcamah, opening ctDNA-guided treatment paradigm in breast cancer | ||
| 08.09. | UCB turns to art for 'Expressing Epilepsy' awareness campaign | ||
| 08.09. | Roche sweeps neurology corporate reputation rankings once again | ||
| 04.09. | Ionis' 'breakthrough' Alexander disease approval establishes pillar of rare disease pipeline | ||
| 04.09. | Daiichi unit American Regent recalls 3 epinephrine batches on particulate, leakage concerns | ||
| 04.09. | The people who stayed with the problem | ||
| 04.09. | UCB's Bimzelx comes from out of the blue to claim August's top pharma ad spending spot | ||
| 03.09. | Fresenius unit dinged in FDA warning letter flagging 'complaint trend' from customers | ||
| 03.09. | Novartis puts MS advocacy on the podium through social media partnership with British Olympian | ||
| 03.09. | FDA files reveal lingering concerns, contrasting views behind Replimune melanoma nod | ||
| 03.09. | Akeso, Summit's ivonescimab extends lives in Keytruda head-to-head trial. What now? | ||
| 02.09. | ARPA-H puts up $125M to bankroll personalized RNA-based drug production | ||
| 02.09. | Novartis telegraphs 130 job cuts amid biologics rethink in Switzerland | ||
| 02.09. | Cellares downsizes New Jersey operations after losing BMS cell therapy contract | ||
| 02.09. | Trump GLP-1 update teases blockbuster annual sales for Lilly from Medicare program: analyst | ||
| 01.09. | Regulatory tracker: Another Tavneos domino falls as UK rescinds authorization |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.